Net Income (Loss) Attributable to Parent in USD of SQZ Biotechnologies Co from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
SQZ Biotechnologies Co quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2019 to Q3 2023.
  • SQZ Biotechnologies Co Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2023 was -$23.6M, a 4.4% decline year-over-year.
  • SQZ Biotechnologies Co Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2023 was -$71.6M, a 7.84% increase year-over-year.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2022 was -$79.5M, a 15.6% decline from 2021.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2021 was -$68.7M, a 36.1% decline from 2020.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2020 was -$50.5M, a 56.9% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

SQZ Biotechnologies Co Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$71.6M -$23.6M -$996K -4.4% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 -$70.6M -$16.8M +$5.47M +24.6% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 -$76.1M -$17.7M +$3.35M +15.9% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q4 2022 -$79.5M -$13.5M -$1.73M -14.6% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2023
Q3 2022 -$77.7M -$22.6M -$193K -0.86% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 -$77.5M -$22.2M -$3.17M -16.6% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$74.4M -$21M -$5.64M -36.6% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 -$68.7M -$11.8M +$5.78M +32.8% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 -$74.5M -$22.5M -$10.1M -81.8% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$64.4M -$19.1M -$9.08M -91% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$55.3M -$15.4M -$4.82M -45.5% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$50.5M -$17.6M 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 -$12.4M -$4.47M -56.7% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$9.99M 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$10.6M 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q3 2019 -$7.88M 01 Jul 2019 30 Sep 2019 10-Q 10 Dec 2020

SQZ Biotechnologies Co Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$79.5M -$10.7M -15.6% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2023
2021 -$68.7M -$18.2M -36.1% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 -$50.5M -$18.3M -56.9% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$32.2M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.